CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-17 | Ives Jeffrey L. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,800 | 0 | ||
| 2023-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +5,161,290 | $7.75 | $40.0M | 13,043,179 |
| 2023-06-06 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | −25,000 | 25,000 | ||
| 2023-06-06 | Stalfort John A III Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-06 | Stoppel Laura Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-06 | Porter Derrell Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-06 | Ives Jeffrey L. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-06 | Fountain Nathan B Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-06 | Drapkin Kimberlee C Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-01-17 | Zuga Matt CFO and Chief Business Officer | Grant or award | +33,500 | 109,687 | ||
| 2023-01-17 | Zuga Matt CFO and Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +150,800 | 150,800 | ||
| 2023-01-17 | Siemers Eric Chief Medical Officer | Grant or award | +26,700 | 26,700 | ||
| 2023-01-17 | Siemers Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +120,200 | 120,200 | ||
| 2023-01-17 | OConnell Daniel Joseph President and CEO | Grant or award | +114,000 | 116,685 | ||
| 2023-01-17 | OConnell Daniel Joseph President and CEO | Grant or award · Employee Stock Option (right to buy) | +472,500 | 472,500 | ||
| 2023-01-17 | Meisner Derek M Chief Legal Office & Corp Sec | Grant or award | +26,800 | 26,800 | ||
| 2023-01-17 | Meisner Derek M Chief Legal Office & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +120,800 | 120,800 | ||
| 2023-01-17 | Barton Russell Chief Operating Officer | Grant or award | +26,700 | 26,700 | ||
| 2023-01-17 | Barton Russell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +120,200 | 120,200 | ||
| 2023-01-04 | Porter Derrell Director | Grant or award · Stock Option Grant (right to buy) | +50,000 | 50,000 |
Page 9 of 13 · 246 trades